Madrigal Pharmaceuticals IncNASDAQ:MDGL
- LAST PRICE280.0400
- TODAY'S CHANGE (%)-3.9500 (-1.3909%)
- Bid / Lots250.0000/ 1
- Ask / Lots280.0400/ 2
- Open / Previous Close283.5600 / 283.9900
- Day Range
- 52 Week Range
- Volume314,071
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MDGL |
|---|---|---|
| 09:32 ET | 1684 | 283.56 |
| 09:34 ET | 500 | 284.44 |
| 09:36 ET | 200 | 285.7256 |
| 09:38 ET | 300 | 284.1778 |
| 09:39 ET | 622 | 284.445 |
| 09:43 ET | 1874 | 284.334 |
| 09:45 ET | 300 | 283.15 |
| 09:48 ET | 915 | 282.46 |
| 09:52 ET | 100 | 282.27 |
| 09:56 ET | 100 | 280.075 |
| 09:57 ET | 500 | 280.44 |
| 10:01 ET | 410 | 281.4 |
| 10:06 ET | 100 | 282.7 |
| 10:08 ET | 200 | 282.7 |
| 10:12 ET | 100 | 283.355 |
| 10:15 ET | 300 | 282.48 |
| 10:19 ET | 100 | 282.05 |
| 10:21 ET | 905 | 281.9 |
| 10:24 ET | 401 | 283.69 |
| 10:26 ET | 443 | 284.125 |
| 10:28 ET | 700 | 283.32 |
| 10:30 ET | 1300 | 283.06 |
| 10:32 ET | 1000 | 282.8 |
| 10:33 ET | 133 | 283.72 |
| 10:35 ET | 200 | 283.5 |
| 10:37 ET | 100 | 283.62 |
| 10:39 ET | 200 | 283.66 |
| 10:44 ET | 1220 | 283.14 |
| 10:46 ET | 3961 | 282.675 |
| 10:50 ET | 318 | 283.3 |
| 10:53 ET | 500 | 284.04 |
| 10:55 ET | 400 | 284 |
| 10:57 ET | 100 | 284.11 |
| 11:02 ET | 232 | 284.215 |
| 11:04 ET | 200 | 283.515 |
| 11:06 ET | 100 | 283.91 |
| 11:09 ET | 100 | 283.58 |
| 11:18 ET | 700 | 283.88 |
| 11:20 ET | 226 | 283.645 |
| 11:22 ET | 100 | 283.744 |
| 11:24 ET | 375 | 283.8013 |
| 11:29 ET | 100 | 283.585 |
| 11:31 ET | 100 | 283.39 |
| 11:33 ET | 100 | 283 |
| 11:36 ET | 100 | 282.465 |
| 11:40 ET | 648 | 282.7 |
| 11:42 ET | 100 | 282.48 |
| 11:49 ET | 100 | 282.805 |
| 11:51 ET | 300 | 282.135 |
| 11:58 ET | 1851 | 281.9058 |
| 12:03 ET | 100 | 282.84 |
| 12:07 ET | 200 | 282.795 |
| 12:16 ET | 141 | 282.46 |
| 12:34 ET | 200 | 281.445 |
| 12:45 ET | 100 | 281.115 |
| 12:48 ET | 395 | 281.635 |
| 12:52 ET | 100 | 282.26 |
| 12:57 ET | 100 | 282.69 |
| 12:59 ET | 205 | 281.67 |
| 01:08 ET | 200 | 282.135 |
| 01:28 ET | 100 | 281.58 |
| 01:30 ET | 135 | 281.8665 |
| 01:32 ET | 200 | 281.64 |
| 01:37 ET | 694 | 281.82 |
| 01:42 ET | 100 | 282.215 |
| 01:53 ET | 100 | 281.91 |
| 01:55 ET | 470 | 282.03 |
| 01:57 ET | 200 | 281.86 |
| 02:00 ET | 100 | 282.57 |
| 02:02 ET | 200 | 282.52 |
| 02:04 ET | 877 | 281.46 |
| 02:08 ET | 1012 | 280.72 |
| 02:09 ET | 763 | 280.505 |
| 02:11 ET | 2709 | 279.8 |
| 02:13 ET | 100 | 280.71 |
| 02:15 ET | 200 | 281.21 |
| 02:18 ET | 100 | 281.36 |
| 02:22 ET | 200 | 281.73 |
| 02:24 ET | 200 | 281.925 |
| 02:27 ET | 200 | 281.89 |
| 02:29 ET | 200 | 282.5 |
| 02:31 ET | 300 | 282.16 |
| 02:36 ET | 401 | 281.87 |
| 02:40 ET | 3881 | 280.77 |
| 02:44 ET | 1000 | 280.285 |
| 02:47 ET | 626 | 280.98 |
| 02:49 ET | 100 | 280.805 |
| 02:51 ET | 100 | 281.025 |
| 02:56 ET | 900 | 281.02 |
| 03:02 ET | 100 | 281.5 |
| 03:03 ET | 100 | 280.57 |
| 03:05 ET | 210 | 280.8399 |
| 03:09 ET | 300 | 280.35 |
| 03:12 ET | 300 | 280.34 |
| 03:14 ET | 265 | 279.7001 |
| 03:16 ET | 1125 | 281.18 |
| 03:18 ET | 100 | 281.16 |
| 03:21 ET | 500 | 280.69 |
| 03:25 ET | 330 | 280.59 |
| 03:27 ET | 100 | 280.27 |
| 03:30 ET | 120 | 280.33 |
| 03:32 ET | 200 | 280.325 |
| 03:34 ET | 200 | 280.15 |
| 03:36 ET | 700 | 280 |
| 03:39 ET | 1600 | 279.825 |
| 03:43 ET | 1900 | 279.92 |
| 03:45 ET | 884 | 280.06 |
| 03:50 ET | 1800 | 278.79 |
| 03:52 ET | 2250 | 279.26 |
| 03:54 ET | 1000 | 279.36 |
| 03:56 ET | 3822 | 280.17 |
| 03:57 ET | 2836 | 279.88 |
| 03:59 ET | 3562 | 280.04 |
Jun 11, 2024
DJ Madrigal Pharmaceuticals Initiated at Outperform by Wolfe Research, from 2:48PM ET on Tuesday Jun 11, 2024 by Dow Jones
2:48PM ET on Tuesday Jun 11, 2024 by Dow Jones
Jun 6, 2024
Jun 5, 2024
Madrigal Pharmaceuticals to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference, from 8:00AM ET on Wednesday Jun 05, 2024 by Dow Jones
8:00AM ET on Wednesday Jun 05, 2024 by Dow JonesDJ S&P 500 Futures Rise In Premarket Trading; Hewlett Packard Ent, CrowdStrike Holdings Lead, from 7:30AM ET on Wednesday Jun 05, 2024 by Dow Jones
7:30AM ET on Wednesday Jun 05, 2024 by Dow Jones
May 29, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Madrigal Pharmaceuticals Inc | 6.1B | -12.1x | --- |
Cytokinetics Inc | 6.3B | -9.8x | --- |
Viking Therapeutics Inc | 5.7B | -51.4x | --- |
Revolution Medicines Inc | 6.4B | -10.3x | --- |
Summit Therapeutics Inc | 5.6B | -48.4x | --- |
Nuvalent Inc | 5.2B | -33.4x | --- |
Company Information
Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH). The Company's product candidate, resmetirom, is a once-daily, oral, liver-directed thyroid hormone receptor-β (THR-β) agonist designed to target key underlying causes of NASH. NASH is a more advanced form of non-alcoholic fatty liver disease (NAFLD). The Company’s clinical development program includes MAESTRO-NASH, MAESTRO-NAFLD-1, and MAESTRO-NASH OUTCOMES.
Contact Information
- Headquarters
- 200 Barr Harbor Dr Ste 400WEST CONSHOHOCKEN, PA, United States 19428-2978
- Phone
- 404-380-9263
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Julian Baker
- President, Chief Executive Officer, Director
- Bill Sibold
- Chief Financial Officer, Senior Vice President
- Mardi Dier
- President of Research and Development, Chief Medical Officer, Director
- Rebecca Taub
- Chief Commercial Officer
- Carole Huntsman
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $6.1B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 21.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.43 |
EPS | $-23.08 |
Book Value | $20.39 |
P/E Ratio | -12.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
